Sideroblastic anaemias

British Journal of Haematology

Volumn 116, Issue 4, 2002, Pages 733-743

  Alcindor, Thierry ^a   Bridges, Kenneth R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anaemia; Haem; Mitochondria; Sideroblastic

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ALCOHOL; CELL ENZYME; ERYTHROPOIETIN; FERRITIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEME; IRON; IRON REGULATORY FACTOR; MESSENGER RNA; MITOCHONDRIAL ENZYME; PYRIDOXINE; REACTIVE OXYGEN METABOLITE; TOXIN; TRANSFERRIN RECEPTOR; UBIQUITIN;

ALCOHOL ABUSE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BONE MARROW; CHROMOSOME 3; ERYTHROBLAST; GENE EXPRESSION; HEME SYNTHESIS; HEREDITY; HUMAN; HYPOTHERMIA; IRON RESPONSIVE ELEMENT; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MYELODYSPLASTIC SYNDROME; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIDEROBLASTIC ANEMIA; STEM CELL; X CHROMOSOME LINKAGE;

ANEMIA, SIDEROBLASTIC; ANTI-BACTERIAL AGENTS; CHELATING AGENTS; CHLORAMPHENICOL; DNA, MITOCHONDRIAL; ETHANOL; GENES, DOMINANT; GENES, RECESSIVE; HEME; HUMANS; IRON; LINKAGE (GENETICS); MYELODYSPLASTIC SYNDROMES; OVERDOSE; VITAMIN B 6 DEFICIENCY; X CHROMOSOME;

EID: 0036118773     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1048.2002.03378.x     Document Type: Review

References (119)

1. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A)
2. Autosomal inheritance of sideroblastic anaemia
3. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease
4. The syndrome of neonatal copper deficiency
5. The myelodysplastic syndromes: Predictive value of eight prognostic systems in 143 cases from a single institution
6. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome
7. Involvement of mitochondrial ferredoxin and Cox15p in hydroxylation of heme O
8. Myelodysplastic syndromes (refractory anemia). Perspective of the biologic, clinical and therapeutic issues
9. Reversible sideroblastic anemia caused by chloramphenicol
10. Human ABC7 transporter: Gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation
11. Iron overload in patients with sideroblastic anaemia is not related to the presence of the haemochromatosis Cys282Tyr and His63Asp mutations
12. Identical mitochon-drial DNA deletion in mother with progressive external oph-thalmoplegia and son with Pearson marrow-pancreas syndrome
13. The putative iron-responsive element in the human erythroid 5-aminolevulinate synthase mRNA mediates translational control
14. Human delta-aminolevulinate synthase: Assignment of the housekeeping gene to 3p21 and erythroid-specific gene to the X chromosome
15. Animal mitochondrial genomes
16. Thiamine-responsive anemia in DIDMOAD syndrome
17. Sideroblastic anaemia
18. Pathophysiology of heme synthesis
19. 5-Aminolevulinate synthase in sideroblastic anemia: mRNA and enzyme activity levels in bone marrow cells
20. Molecular defects of erythroid 5-aminolevulinate syn-thase in X-linked sideroblastic anemia
21. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression
22. Bone marrow δ-aminolevulinic acid synthetase deficiency in a female withcongenital sideroblastic anemia
23. Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis
24. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females
25. A severe type of hereditary anemia with elliptocytosis
26. Anemia in children with splenomegaly and peculiar changes in bones: Report of cases
27. Widespread multi-tissue deletions of the mitochondrial genome in the Pear-son marrow-pancreas syndrome
28. Assignment of human erythroid delta-aminolevulinate synthase (ALAS2) to a distal subregion of band Xp11.21 by PCR analysis of somatic cell hybrids containing X: Autosome translocations
29. Enzymatic defect in 'X-linked' sideroblastic anemia: Molecular evidence for eryth-roid delta-aminolevulinate synthase deficiency
30. X-linked side-roblastic anemia: Identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley
31. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: Increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coin-heritance of hereditary hemochromatosis
32. Erythroid 5-aminolevulinate synthase is located on the X chromosome
33. Human erythroid 5′-aminolevulinate synthase: Promoter analysis and identification of an iron-responsive element in the mRNA
34. Identification of a highly polymorphic marker within intron 7 of the ALAS2 gene and suggestion of at least two loci for X-linked sideroblastic anemia
35. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase
36. Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA
37. Copper deficiency in humans
38. Congenital sideroblastic anaemia in two girls
39. Identification of an arginine452 to histidine substitution in the erythroid 5-aminolaevulinate synthetase gene in a large pedigree with X-linked hereditary sideroblastic anaemia
40. Mitochondrial cytopathy. A multisystem disorder with ragged red fibres on muscle biopsy
41. 5-Aminolevulinate synthase and the first step of heme biosynthesis
42. Sideroblastic anaemia with iron overload presenting as an arthropathy
43. Ineffective erythropoiesis in myelodysplastic syndromes: Correlation with Fas expression but not with lack of erythropoietin receptor signal transduction
44. Sideroblastic anemia associated with iron overload treated by repeated phlebotomy
45. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia
46. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes
47. Two types of acquired idiopathic sideroblastic anaemia (AISA)
48. A heteroplasmic point mutation of mitochondrial tRNALeu (CUN) in non-lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemia
49. Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia
50. Two types of acquired idiopathic sideroblastic anaemia (AISA): A time-tested distinction
51. Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia
52. Lead toxicity: Current concerns
53. A comparative electron microscopic study of refractory and alcoholic sideroblastic anaemia
54. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts
55. Pyridoxine-responsive sideroblastic anemia due to antituberculous drugs
56. Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1
57. Pyridoxine responsive hereditary sideroblastic ery-thropoiesis and iron overload: Two microcytic subpopulations in the affected male, one normocytic and one microcytic sub-population in the obligate female carrier
58. Sideroblasts in myelodysplasia: Their nature and clinical significance
59. Treatment of anemia in myelodys-plastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: Results from a randomized phase II study and long-term follow-up of 71 patients
60. Purification of all forms of Hela cell mitochondrial DNA and assessment of damage to it caused by hydrogen peroxide treatment of mitochondria or cells
61. Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria
62. Effect of pyridoxine plus chronic phlebotomy on the function and morphology of bone marrow and liver in pyr-idoxine-responsive sideroblastic anemia
63. Studies on the pathogenesis of alcohol-induced sideroblastic bone-marrow abnormalities
64. Myopathy, lactic acidosis, and sideroblastic anemia: A new syndrome
65. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)
66. Origin and persistence of the mitochondrial genome
67. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: Exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis
68. Homologous nuclear-encoded mitochondrial and cytosolic isoproteins. A review of structure, biosynthesis and genes
69. Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome
70. Hereditary sideroblastic anaemia in 4 siblings of a Libyan family - Autosomal inheritance
71. Mitochondrial cytopathy with lactic acidosis, carnitine deficiency and DeToni-Fanconi-Debre syndrome
72. Cis-trans models for post-transcriptional gene regulation
73. Sideroblastic anemias: Variations on imprecision in diagnostic criteria, proposal for an extended classification of sideroblastic anemias
74. Haem synthesis in side-roblastic anaemia
75. The discovery of the division apparatus of plastids and mitochondria
76. Alcohol and the blood
77. Pyridoxal 5′-phosphate and pyridoxamine 5′-phosphate concentrations in blood and tissues of mice fed ethanol-containing liquid diets
78. Chloramphenicol-induced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE-IRP interactions
79. Nutritional anemia in alcoholism
80. - in the production of HO. in vitro and in vivo
81. Ubiquinol: Cytochrome c oxidoreductase (complex III). Effect of inhibitors on cytochrome b reduction in submitochondrial particles and the role of ubiquinone in complex III
82. Increased apoptosis in acquired sideroblastic anaemia
83. Acute ethanol ingestion and haem biosynthesis in healthy subjects
84. Sideroblastic anaemia
85. Erythroblast iron metabolism in sideroblastic marrows
86. Translational control of 5-aminolevulinate synthase mRNA by iron-responsive elements in erythroid cells
87. Intestinal hydrolysis of pyridoxal 5′-phosphate in vitro and in vivo in the rat: Effect of ethanol
88. Sideroblastic anemia showing unique response to pyridoxine
89. Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: Evidence for in vivo synergy
90. Recurrent thrombocytopenia, erythroid hypoplasia and sideroblastic anaemia associated with hypothermia
91. Lipid peroxidation products mediate the formation of 8-hydroxydeoxyguanosine in DNA
92. Coproporphyrinogen oxidase activity and porphyrin concentrations in peripheral red blood cells in hereditary sideroblastic anaemia
93. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction
94. Acquired sideroblastic anaemia induced by a copper-chelating agent
95. Globin chain synthesis ratios in sideroblastic anaemia
96. Iron overload in mild sideroblastic anaemias
97. Clinical studies in alcoholic sideroblastosis
98. X-linked sideroblastic anemia and ataxia: Linkage to phosphoglycerate kinase at Xq13
99. Effect of chloramphenicol on reticulocyte delta-aminolaevulinic acid synthetase in rabbits
100. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300)
101. Histopathology of mitochondrial cytopathy and the Laurence-Moon-Biedl syndrome
102. Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload
103. Congenital sideroblastic anaemia in a girl
104. Study of a female with congenital sideroblastic anemia
105. Anti-tuberculous drugs and sideroblastic anaemia
106. Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia
107. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes
108. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein
109. WFS1 (Wolfram syndrome 1) gene product: Predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain
110. Lethal damage to endothelial cells by oxidized low density lipoprotein: Role of selenoperoxidases in cytoprotection against lipid hydroperoxide-and iron-mediated reactions
111. Congenital sideroblastic anemia successfully treated by allogeneic bone marrow transplantation
112. Hereditary sideroblastic anaemia and autosomal inheritance of erythrocyte dimorphism in a Dutch family
113. The 'ferrous-oxy' intermediate in the reaction of dioxygen with fully reduced cytochromes aa3 and bo3
114. Porphyrin synthesis and heme synthetase activity in pyridoxine-responsive anemia
115. Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I
116. Myeloproliferative syndrome with sideroblastic anemia and acquired hemoglobin H disease
117. Drug-induced mitochondrial damage and sideroblastic change
118. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukemia
119. Observations on the anemia and neutropenia of human copper deficiency